Specifically, both C15:0 and metformin had significant, dose-dependent effects on lowering: HLA-DR in the 3C system relevant to cardiovascular disease and chronic inflammation; and CD38, CD69, and T cell proliferation in the SAg cell system relevant to autoimmune disease and chronic inflammation. Here, CD38 is linked to autoimmune disease.